Jiangan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jiangan Li has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Lulu Ni
Department of Emergency, Jiangnan University Medical Center (Wuxi No. 2 People’s Hospital), Wuxi School of Medicine, Jiangnan University, Wuxi, China
5 shared publicationsHongli Ren
Department of Basic Medicine, Jiangnan University, Wuxi, China
3 shared publications- Shuo Wang
Department of Neurosurgery, Beijing Tiantan Hospital, China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China
3 shared publications Zhongjie Li
Department of Basic Medicine, Jiangnan University, Wuxi, China
3 shared publicationsHongwei He
Department of Neurosurgery, Beijing Tiantan Hospital, China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China
2 shared publicationsPing Sun
Department of Pathology
2 shared publications
Latest Publications
- 11 October 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1037, 179397
D-limonene pretreatment attenuates acute myocardial infarction injury and modulates PPARα-associated fatty acid oxidation and inflammatory stress
- 11 October 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1037, 179397
D-limonene pretreatment attenuates acute myocardial infarction injury and modulates PPARα-associated fatty acid oxidation and inflammatory stress
- Open Access
- 13 March 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (11) , e48027
Association of systemic immune-inflammation index (SII) with 28-day all-cause mortality in acute heart failure: A retrospective cohort study
This study aimed to investigate the association between the systemic immune-inflammation index (SII) and 28-day all-cause mortality in patients with acute heart failure (AHF) and to evaluate the potential of SII as a prognostic biomarker for early risk stratification. A retrospective cohort study was conducted using the Medical Information Mart for Intensive Care IV database. Patients with an AHF diagnosis on first intensive care unit admission were included, while those with intensive care unit stays P < .001). In multivariable Cox models, compared with the lowest tertile, the middle and highest SII tertiles were associated with higher 28-day mortality (hazard ratio = 1.485, 95% confidence interval: 1.193–1.849 and hazard ratio = 2.497, 95% confidence interval: 2.060–3.028; both P < .01). Similar associations were observed for 90-, 180-, and 365-day mortality. Restricted cubic spline analyses suggested a dose–response relationship between SII and 28-day mortality. In addition, adding SII to Acute Physiology Score III and Sequential Organ Failure Assessment improved discrimination for 28-day mortality in receiver operating characteristic analyses. Elevated SII is an independent predictor of increased 28-day all-cause mortality in AHF patients. As a readily available and cost-effective marker, SII could be integrated into early risk stratification protocols to guide personalized therapeutic strategies in acute care settings.
- 13 March 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (11) , e48027
Open AccessAssociation of systemic immune-inflammation index (SII) with 28-day all-cause mortality in acute heart failure: A retrospective cohort study
This study aimed to investigate the association between the systemic immune-inflammation index (SII) and 28-day all-cause mortality in patients with acute heart failure (AHF) and to evaluate the potential of SII as a prognostic biomarker for early risk stratification. A retrospective cohort study was conducted using the Medical Information Mart for Intensive Care IV database. Patients with an AHF diagnosis on first intensive care unit admission were included, while those with intensive care unit stays P < .001). In multivariable Cox models, compared with the lowest tertile, the middle and highest SII tertiles were associated with higher 28-day mortality (hazard ratio = 1.485, 95% confidence interval: 1.193–1.849 and hazard ratio = 2.497, 95% confidence interval: 2.060–3.028; both P < .01). Similar associations were observed for 90-, 180-, and 365-day mortality. Restricted cubic spline analyses suggested a dose–response relationship between SII and 28-day mortality. In addition, adding SII to Acute Physiology Score III and Sequential Organ Failure Assessment improved discrimination for 28-day mortality in receiver operating characteristic analyses. Elevated SII is an independent predictor of increased 28-day all-cause mortality in AHF patients. As a readily available and cost-effective marker, SII could be integrated into early risk stratification protocols to guide personalized therapeutic strategies in acute care settings.
- 22 July 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-9
Socioeconomic status, individual behaviors and the risk of aneurysmal subarachnoid hemorrhage: a Mendelian randomization study
Background Socioeconomic status (SES) and individual behaviors (IB) has significant effect on human health. However, the connection between SES/IB and aneurysmal subarachnoid hemorrhage (aSAH) has not been thoroughly explored. Hence, we performed MR analyses to explore the causal relationship between SES/IB and aSAH at the genetic level. Methods We conducted a two-sample MR analysis to examine causal relationship of SES and IB (physical activity, smoking behaviors, drinking behaviors, sleeping behaviors and sedentary behaviors) on aSAH. A series of filtering steps were taken to select eligible genetic instruments robustly associated with each of factors. Inverse variance weighting (IVW) methods was used as the main method of two-stage MR analysis, and was supplemented by the weighted median method, maximum likelihood method, simple median MR method and Mendelian randomization robust adjusted profile score. Multiple sensitivity analyses were used to test the robustness of MR methods. Results We found that educational attainment (OR, 0.236; 95% CI, 0.164–0.340; P = 6.808 × 10− 15) and moderate to vigorous physical activity (OR, 0.037; 95% CI, 0.003–0.392; P = 0.006) were identified as the protective factor for aSAH, while smoking initiation (OR, 1.879; 95% CI, 1.378–2.561; P = 6.602 × 10− 6), number of cigarettes per day (OR, 3.048; 95% CI, 1.679–5.535; P = 2.504 × 10− 4), insomnia (OR, 1.229; 95% CI, 1.029–1.468; P = 0.023), television watching time (OR, 3.122; 95% CI, 1.768–5.513; P = 8.698 × 10− 5) and leisure screen time (OR, 1.603; 95% CI, 1.116–2.303; P = 0.011) were associated with increased risk of aSAH. Four additional MR analysis methods yielded similar results to the IVW method. Multiple sensitivity analyses showed that the results were stable and robust. Conclusions MR study provides robust evidence that educational attainment and moderate to vigorous physical activity were the protective factor for aSAH, while smoking initiation, number of cigarettes per day, insomnia, television watching time and leisure screen time were associated with an increased risk of aSAH.
- 22 July 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-9
Socioeconomic status, individual behaviors and the risk of aneurysmal subarachnoid hemorrhage: a Mendelian randomization study
Background Socioeconomic status (SES) and individual behaviors (IB) has significant effect on human health. However, the connection between SES/IB and aneurysmal subarachnoid hemorrhage (aSAH) has not been thoroughly explored. Hence, we performed MR analyses to explore the causal relationship between SES/IB and aSAH at the genetic level. Methods We conducted a two-sample MR analysis to examine causal relationship of SES and IB (physical activity, smoking behaviors, drinking behaviors, sleeping behaviors and sedentary behaviors) on aSAH. A series of filtering steps were taken to select eligible genetic instruments robustly associated with each of factors. Inverse variance weighting (IVW) methods was used as the main method of two-stage MR analysis, and was supplemented by the weighted median method, maximum likelihood method, simple median MR method and Mendelian randomization robust adjusted profile score. Multiple sensitivity analyses were used to test the robustness of MR methods. Results We found that educational attainment (OR, 0.236; 95% CI, 0.164–0.340; P = 6.808 × 10− 15) and moderate to vigorous physical activity (OR, 0.037; 95% CI, 0.003–0.392; P = 0.006) were identified as the protective factor for aSAH, while smoking initiation (OR, 1.879; 95% CI, 1.378–2.561; P = 6.602 × 10− 6), number of cigarettes per day (OR, 3.048; 95% CI, 1.679–5.535; P = 2.504 × 10− 4), insomnia (OR, 1.229; 95% CI, 1.029–1.468; P = 0.023), television watching time (OR, 3.122; 95% CI, 1.768–5.513; P = 8.698 × 10− 5) and leisure screen time (OR, 1.603; 95% CI, 1.116–2.303; P = 0.011) were associated with increased risk of aSAH. Four additional MR analysis methods yielded similar results to the IVW method. Multiple sensitivity analyses showed that the results were stable and robust. Conclusions MR study provides robust evidence that educational attainment and moderate to vigorous physical activity were the protective factor for aSAH, while smoking initiation, number of cigarettes per day, insomnia, television watching time and leisure screen time were associated with an increased risk of aSAH.
- 22 July 2024
- Published by Springer Nature in Translational Stroke Research
- Vol. 16 (4) , 1062-1074
A Decision Tree Model to Help Treatment Decision-Making for Unruptured Intracranial Aneurysms: A Multi-center, Long-Term Follow-up Study in a Large Chinese Cohort
Chinese population have a high prevalence of unruptured intracranial aneurysm (UIA). Clinical and imaging risk factors predicting UIA growth or rupture are
- 22 July 2024
- Published by Springer Nature in Translational Stroke Research
- Vol. 16 (4) , 1062-1074
A Decision Tree Model to Help Treatment Decision-Making for Unruptured Intracranial Aneurysms: A Multi-center, Long-Term Follow-up Study in a Large Chinese Cohort
Chinese population have a high prevalence of unruptured intracranial aneurysm (UIA). Clinical and imaging risk factors predicting UIA growth or rupture are
- Open Access
- 7 November 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (2) , 788-798
A decision tree model to help treatment decision-making for severe spontaneous intracerebral hemorrhage
Background: Surgical treatment demonstrated a reduction in mortality among patients suffering from severe spontaneous intracerebral hemorrhage (SSICH). However, which SSICH patients could benefit from surgical treatment was unclear. This study aimed to establish and validate a decision tree (DT) model to help determine which SSICH patients could benefit from surgical treatment. Materials and methods: SSICH patients from a prospective, multicenter cohort study were analyzed retrospectively. The primary outcome was the incidence of neurological poor outcome (modified Rankin scale as 4–6) on the 180th day posthemorrhage. Then, surgically-treated SSICH patients were set as the derivation cohort (from a referring hospital) and validation cohort (from multiple hospitals). A DT model to evaluate the risk of 180-day poor outcome was developed within the derivation cohort and validated within the validation cohort. The performance of clinicians in identifying patients with poor outcome before and after the help of the DT model was compared using the area under curve (AUC). Results: One thousand two hundred sixty SSICH patients were included in this study (middle age as 56, and 984 male patients). Surgically-treated patients had a lower incidence of 180-day poor outcome compared to conservatively-treated patients (147/794 vs. 128/466, PP<0.001). Conclusions: This study provided a DT model for predicting the poor outcome of SSICH patients postsurgically, which may serve as a useful tool assisting clinicians in treatment decision-making for SSICH.
- 7 November 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (2) , 788-798
Open AccessA decision tree model to help treatment decision-making for severe spontaneous intracerebral hemorrhage
Background: Surgical treatment demonstrated a reduction in mortality among patients suffering from severe spontaneous intracerebral hemorrhage (SSICH). However, which SSICH patients could benefit from surgical treatment was unclear. This study aimed to establish and validate a decision tree (DT) model to help determine which SSICH patients could benefit from surgical treatment. Materials and methods: SSICH patients from a prospective, multicenter cohort study were analyzed retrospectively. The primary outcome was the incidence of neurological poor outcome (modified Rankin scale as 4–6) on the 180th day posthemorrhage. Then, surgically-treated SSICH patients were set as the derivation cohort (from a referring hospital) and validation cohort (from multiple hospitals). A DT model to evaluate the risk of 180-day poor outcome was developed within the derivation cohort and validated within the validation cohort. The performance of clinicians in identifying patients with poor outcome before and after the help of the DT model was compared using the area under curve (AUC). Results: One thousand two hundred sixty SSICH patients were included in this study (middle age as 56, and 984 male patients). Surgically-treated patients had a lower incidence of 180-day poor outcome compared to conservatively-treated patients (147/794 vs. 128/466, PP<0.001). Conclusions: This study provided a DT model for predicting the poor outcome of SSICH patients postsurgically, which may serve as a useful tool assisting clinicians in treatment decision-making for SSICH.
- Open Access
- 10 May 2023
- Published by Elsevier in Science Bulletin
- Vol. 68 (11) , 1162-1175
The markers and risk stratification model of intracranial aneurysm instability in a large Chinese cohort
- 10 May 2023
- Published by Elsevier in Science Bulletin
- Vol. 68 (11) , 1162-1175
Open AccessThe markers and risk stratification model of intracranial aneurysm instability in a large Chinese cohort
- Open Access
- 31 January 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12, 775514
Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma
Background: Berberine is one of the most interesting and promising natural anticancer drugs. POLE2 is involved in many cellular functions such as DNA replication and is highly expressed in a variety of cancers. However, the specific molecular mechanism of berberine interfering with POLE2 expression in lung adenocarcinoma (LUAD) is still unknown to a great extent.Method: The KEGG database (Release 91.0) and Gene Ontology (GO) category database were used for functional annotation of differentially expressed genes after berberine treatment. Reproducibility assessment using TCGA dataset. The biological functions of berberine in LUAD were investigated by a series of in vitro and in vivo experiments: MTT, colony formation, mouse xenograft and plasmid transfection. The molecular mechanisms of berberine were demonstrated by plasmid transfection, quantitative RT-PCR and Western blotting.Result: The elevated expression of FOXM1 and the high enrichment of DNA replication pathway were confirmed in LUAD by microarray and TCGA analysis, and were positively correlated with poor prognosis. Functionally, berberine inhibited the proliferation and survival of LUAD cell lines in vitro and in vivo. Mechanistically, berberine treatment down regulated the expression of FOXM1which closely related to survival, survival related genes in Cell cycle and DNA replication pathway, and significantly down regulated the expression of survival related POLE2. Interestingly, we found that the transcription factor FOXM1 could act as a bridge between berberine and POLE2.Conclusion: Berberine significantly inhibited LUAD progression via the FOXM1/POLE2, and FOXM1/POLE2 may act as a clinical prognostic factor and a therapeutic target for LUAD. Berberine may be used as a promising therapeutic candidate for LUAD patients.
- 31 January 2022
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12, 775514
Open AccessBerberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma
Background: Berberine is one of the most interesting and promising natural anticancer drugs. POLE2 is involved in many cellular functions such as DNA replication and is highly expressed in a variety of cancers. However, the specific molecular mechanism of berberine interfering with POLE2 expression in lung adenocarcinoma (LUAD) is still unknown to a great extent.Method: The KEGG database (Release 91.0) and Gene Ontology (GO) category database were used for functional annotation of differentially expressed genes after berberine treatment. Reproducibility assessment using TCGA dataset. The biological functions of berberine in LUAD were investigated by a series of in vitro and in vivo experiments: MTT, colony formation, mouse xenograft and plasmid transfection. The molecular mechanisms of berberine were demonstrated by plasmid transfection, quantitative RT-PCR and Western blotting.Result: The elevated expression of FOXM1 and the high enrichment of DNA replication pathway were confirmed in LUAD by microarray and TCGA analysis, and were positively correlated with poor prognosis. Functionally, berberine inhibited the proliferation and survival of LUAD cell lines in vitro and in vivo. Mechanistically, berberine treatment down regulated the expression of FOXM1which closely related to survival, survival related genes in Cell cycle and DNA replication pathway, and significantly down regulated the expression of survival related POLE2. Interestingly, we found that the transcription factor FOXM1 could act as a bridge between berberine and POLE2.Conclusion: Berberine significantly inhibited LUAD progression via the FOXM1/POLE2, and FOXM1/POLE2 may act as a clinical prognostic factor and a therapeutic target for LUAD. Berberine may be used as a promising therapeutic candidate for LUAD patients.
- Open Access
- 14 September 2021
- Published by Springer Nature in Research Square
Berberine Inhibits FoxM1 Dependent Transcriptional Regulation of POLE2 and Interferes with the Survival of Lung Adenocarcinoma
Background:Berberine is one of the most interesting and promising natural anticancer drugs. POLE2 is involved in many cellular functions such as DNA replication and is highly expressed in a variety of cancers. However, the specific molecular mechanism of berberine interfering with POLE2 expression in lung adenocarcinoma (LUAD) is still unknown to a great extent.Method:The KEGG database (Release 91.0) and Gene Ontology (GO) category database were used for functional annotation of differentially expressed genes after berberine treatment. Reproducibility assessment using TCGA dataset. The biological functions of berberine in LUAD were investigated by a series of in vitro and in vivo experiments: MTT, colony formation, mouse xenograft and plasmid transfection. The molecular mechanisms of berberine were demonstrated by plasmid transfection, quantitative RT-PCR and Western blotting.Result:The elevated expression of FoxM1 and the high enrichment of DNA replication pathway were confirmed in LUAD by microarray and TCGA analysis, and were positively correlated with poor prognosis. Functionally, berberine inhibited the proliferation and survival of LUAD cell lines in vitro and in vivo. Mechanistically, berberine treatment down regulated the expression of FoxM1which closely related to survival, survival related genes in cell cycle and DNA replication pathway, and significantly down regulated the expression of survival related POLE2. Interestingly, we found that the transcription factor FoxM1 could act as a bridge between berberine and POLE2.Conclusion: Berberine significantly inhibited LUAD progression via the FoxM1/POLE2, and FoxM1/POLE2 may act as a clinical prognostic factor and a therapeutic target for LUAD. Berberine may be used as a promising therapeutic candidate for LUAD patients.
- 14 September 2021
- Published by Springer Nature in Research Square
Open AccessBerberine Inhibits FoxM1 Dependent Transcriptional Regulation of POLE2 and Interferes with the Survival of Lung Adenocarcinoma
Background:Berberine is one of the most interesting and promising natural anticancer drugs. POLE2 is involved in many cellular functions such as DNA replication and is highly expressed in a variety of cancers. However, the specific molecular mechanism of berberine interfering with POLE2 expression in lung adenocarcinoma (LUAD) is still unknown to a great extent.Method:The KEGG database (Release 91.0) and Gene Ontology (GO) category database were used for functional annotation of differentially expressed genes after berberine treatment. Reproducibility assessment using TCGA dataset. The biological functions of berberine in LUAD were investigated by a series of in vitro and in vivo experiments: MTT, colony formation, mouse xenograft and plasmid transfection. The molecular mechanisms of berberine were demonstrated by plasmid transfection, quantitative RT-PCR and Western blotting.Result:The elevated expression of FoxM1 and the high enrichment of DNA replication pathway were confirmed in LUAD by microarray and TCGA analysis, and were positively correlated with poor prognosis. Functionally, berberine inhibited the proliferation and survival of LUAD cell lines in vitro and in vivo. Mechanistically, berberine treatment down regulated the expression of FoxM1which closely related to survival, survival related genes in cell cycle and DNA replication pathway, and significantly down regulated the expression of survival related POLE2. Interestingly, we found that the transcription factor FoxM1 could act as a bridge between berberine and POLE2.Conclusion: Berberine significantly inhibited LUAD progression via the FoxM1/POLE2, and FoxM1/POLE2 may act as a clinical prognostic factor and a therapeutic target for LUAD. Berberine may be used as a promising therapeutic candidate for LUAD patients.
- 27 August 2021
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 49 (1) , 134-144
Berberine inhibits non‐small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis
At present, there are still many problems in the treatment of lung cancer, such as high cost, side effects and low quality of life. The advantages of traditional Chinese medicine (TCM) in the treatment of lung cancer are reflected. Berberine has been increasingly popular in colorectal cancer treatment, but little is known about its bioactivity against non‐small cell lung cancer (NSCLC). Cell proliferation, cell apoptosis, cDNA microarray, gene and protein expression, and NSCLC transplanted tumour growth were performed. Berberine suppressed NSCLC cell proliferation and colony formation in vitro and inhibited NSCLC tumour growth in subcutaneously transplanted tumour lung tumour models, leading to prolonged survival of tumour‐bearing mice. However, berberine did not induce the cleavage of Caspase 3 and PARP1, and could not induce apoptosis in all NSCLC cells. Moreover, 646 genes were differentially expressed upon berberine administration, which were involved in seven signal pathways, such as DNA replication. In cDNA microarray, berberine downregulated the expression of RRM1, RRM2, LIG1, POLE2 that involving DNA repair and replication. Our findings demonstrate that berberine inhibits NSCLC cells growth through repressing DNA repair and replication rather than through apoptosis. Berberine could be used as a promising therapeutic candidate for NSCLC patients.
- 27 August 2021
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 49 (1) , 134-144
Berberine inhibits non‐small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis
At present, there are still many problems in the treatment of lung cancer, such as high cost, side effects and low quality of life. The advantages of traditional Chinese medicine (TCM) in the treatment of lung cancer are reflected. Berberine has been increasingly popular in colorectal cancer treatment, but little is known about its bioactivity against non‐small cell lung cancer (NSCLC). Cell proliferation, cell apoptosis, cDNA microarray, gene and protein expression, and NSCLC transplanted tumour growth were performed. Berberine suppressed NSCLC cell proliferation and colony formation in vitro and inhibited NSCLC tumour growth in subcutaneously transplanted tumour lung tumour models, leading to prolonged survival of tumour‐bearing mice. However, berberine did not induce the cleavage of Caspase 3 and PARP1, and could not induce apoptosis in all NSCLC cells. Moreover, 646 genes were differentially expressed upon berberine administration, which were involved in seven signal pathways, such as DNA replication. In cDNA microarray, berberine downregulated the expression of RRM1, RRM2, LIG1, POLE2 that involving DNA repair and replication. Our findings demonstrate that berberine inhibits NSCLC cells growth through repressing DNA repair and replication rather than through apoptosis. Berberine could be used as a promising therapeutic candidate for NSCLC patients.